News

Experiment with Viagra for pregnant women stopped after 11 babies die

A Dutch study into the effect of Viagra on babies with a groeibeperking is stopped prematurely because the risk of death did increase.

Eleven Dutch hospitals names since 2015 as part of a study into the effects of sildenafil (sold under the brand name of Viagra) during pregnancy, with a baby-in-the-making that suffers from a severe groeibeperking. The hospitals, which is based on research which showed that the means blood flow to the placenta is stimulated, which, in turn, the growth of the unborn foetus would benefit.

In total, 183 pregnant women part, but on Monday, the Amsterdam medical centre and the UNIVERSITY to immediately stop the study. From the interim findings was made according to the UMC found that the gezondheidsnadelen were too big. ‘The chance of a lung disease and also the chance of a death after birth seems to be increased’, it sounds.

Lung disease

Slightly more than half of the participating women took effective sildenafil. 90 women took a placebo. With the babies of the first group died there 19 in total, of whom 11 by a lung disease who may be at sildenafil was related. Six other babies also had a lung disease, but they died not.

In the placebo group died, a total of 9 babies, but, according to the UMC no baby to a lung disease. Three babies had lung disease, but there are not to death.

15 women who participated in the experiment have yet to give birth.

Gynecologist Wessel Ganzevoort, who was head of the research, says ‘shocked’ by the results. ‘The last thing we wanted, patients to hurt.’ He played the results to his own words, by Canadian researchers that a similar research.

Sildenafil was originally by farmareus Pfizer-developed, but the patent is now expired, so the drug now generic is available. Pfizer has not yet responded to the news.

Leave a Comment